CN113288912A - 一种云母发酵液在抑制幽门螺旋杆菌方面的应用 - Google Patents
一种云母发酵液在抑制幽门螺旋杆菌方面的应用 Download PDFInfo
- Publication number
- CN113288912A CN113288912A CN202110703255.4A CN202110703255A CN113288912A CN 113288912 A CN113288912 A CN 113288912A CN 202110703255 A CN202110703255 A CN 202110703255A CN 113288912 A CN113288912 A CN 113288912A
- Authority
- CN
- China
- Prior art keywords
- mica
- helicobacter pylori
- fermentation liquor
- fermentation
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 57
- 230000004151 fermentation Effects 0.000 title claims abstract description 57
- 239000010445 mica Substances 0.000 title claims abstract description 52
- 229910052618 mica group Inorganic materials 0.000 title claims abstract description 52
- 241000590002 Helicobacter pylori Species 0.000 title claims abstract description 42
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 42
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 239000000022 bacteriostatic agent Substances 0.000 claims description 11
- 229910052604 silicate mineral Inorganic materials 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000001093 anti-cancer Effects 0.000 abstract description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 230000007365 immunoregulation Effects 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000002609 medium Substances 0.000 description 11
- 239000010438 granite Substances 0.000 description 10
- 239000003978 infusion fluid Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000021018 plums Nutrition 0.000 description 5
- 238000007789 sealing Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- UZKWTJUDCOPSNM-UHFFFAOYSA-N 1-ethenoxybutane Chemical compound CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 244000141353 Prunus domestica Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000006781 columbia blood agar Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- NMRPBPVERJPACX-UHFFFAOYSA-N (3S)-octan-3-ol Natural products CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- POEDHWVTLBLWDA-UHFFFAOYSA-N 1-butylindole-2,3-dione Chemical compound C1=CC=C2N(CCCC)C(=O)C(=O)C2=C1 POEDHWVTLBLWDA-UHFFFAOYSA-N 0.000 description 1
- PZHIWRCQKBBTOW-UHFFFAOYSA-N 1-ethoxybutane Chemical compound CCCCOCC PZHIWRCQKBBTOW-UHFFFAOYSA-N 0.000 description 1
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- AQZGPSLYZOOYQP-UHFFFAOYSA-N Diisoamyl ether Chemical compound CC(C)CCOCCC(C)C AQZGPSLYZOOYQP-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 235000011230 Prunus domestica subsp. italica Nutrition 0.000 description 1
- 244000249693 Reneklode Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110703255.4A CN113288912A (zh) | 2021-06-24 | 2021-06-24 | 一种云母发酵液在抑制幽门螺旋杆菌方面的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110703255.4A CN113288912A (zh) | 2021-06-24 | 2021-06-24 | 一种云母发酵液在抑制幽门螺旋杆菌方面的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113288912A true CN113288912A (zh) | 2021-08-24 |
Family
ID=77329313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110703255.4A Pending CN113288912A (zh) | 2021-06-24 | 2021-06-24 | 一种云母发酵液在抑制幽门螺旋杆菌方面的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113288912A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113893275A (zh) * | 2021-10-26 | 2022-01-07 | 吉林市国科医工科技发展有限公司 | 一种治疗幽门螺旋杆菌感染的药物组合物 |
CN114191449A (zh) * | 2021-12-14 | 2022-03-18 | 吉林大学 | 一种抑菌凝胶及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110628826A (zh) * | 2019-09-25 | 2019-12-31 | 沃古曼生物科技(吉林)有限公司 | 一种含有活性云母的组合物及其生物发酵制备方法 |
CN111011856A (zh) * | 2019-12-19 | 2020-04-17 | 南京圣诺生物科技实业有限公司 | 用于缓解胃病的组合物、其制备方法及用于缓解胃病的食品 |
CN111568812A (zh) * | 2020-05-22 | 2020-08-25 | 烟台新时代健康产业日化有限公司 | 一种抑制幽门螺旋杆菌的牙膏及其制备方法 |
CN112245482A (zh) * | 2020-10-29 | 2021-01-22 | 吉林大学 | 含有活性云母的组合物在制备提高细胞内超氧化物歧化酶活性的药物中的应用 |
CN112408408A (zh) * | 2020-12-02 | 2021-02-26 | 吉林大学 | 一种含有活性云母的组合物在抑菌活性中的应用 |
-
2021
- 2021-06-24 CN CN202110703255.4A patent/CN113288912A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110628826A (zh) * | 2019-09-25 | 2019-12-31 | 沃古曼生物科技(吉林)有限公司 | 一种含有活性云母的组合物及其生物发酵制备方法 |
CN111011856A (zh) * | 2019-12-19 | 2020-04-17 | 南京圣诺生物科技实业有限公司 | 用于缓解胃病的组合物、其制备方法及用于缓解胃病的食品 |
CN111568812A (zh) * | 2020-05-22 | 2020-08-25 | 烟台新时代健康产业日化有限公司 | 一种抑制幽门螺旋杆菌的牙膏及其制备方法 |
CN112245482A (zh) * | 2020-10-29 | 2021-01-22 | 吉林大学 | 含有活性云母的组合物在制备提高细胞内超氧化物歧化酶活性的药物中的应用 |
CN112408408A (zh) * | 2020-12-02 | 2021-02-26 | 吉林大学 | 一种含有活性云母的组合物在抑菌活性中的应用 |
Non-Patent Citations (3)
Title |
---|
WANGXUE: "青梅酵素的功效与作用及危害", 《网址:Z.XIZIWANG.NET/MEIZI/91065/》 * |
消化界: "Hp感染治疗如何打破困境?微量元素锌在幽门螺杆菌治疗中的应用", 《网址:NEW.QQ.COM/OMN/20200924/20200924A06ZIF00.HTML》 * |
陆恒: "如何防止溃疡病复发", 《胃肠病病人最关心的288个问题》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113893275A (zh) * | 2021-10-26 | 2022-01-07 | 吉林市国科医工科技发展有限公司 | 一种治疗幽门螺旋杆菌感染的药物组合物 |
CN114191449A (zh) * | 2021-12-14 | 2022-03-18 | 吉林大学 | 一种抑菌凝胶及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113288912A (zh) | 一种云母发酵液在抑制幽门螺旋杆菌方面的应用 | |
CN101524375B (zh) | 灵芝孢子粉的湿法破壁方法 | |
CN103301131A (zh) | 注射用哌拉西林钠舒巴坦钠制备方法 | |
CN103497861A (zh) | 一种稠酒的制作方法 | |
CN107184702B (zh) | 一种防治家禽腺胃炎肌胃炎的中药组合物及其制备方法 | |
CN105385640A (zh) | 格氏乳球菌及其应用 | |
CN106668331A (zh) | 一种具有消炎抑菌及促进创面愈合的组合物及制配方法 | |
CN109354628A (zh) | 一种低聚木糖的制备方法及其应用 | |
CN110882236A (zh) | 一种抗肿瘤组合物、治疗癌症的药物制剂及其应用 | |
CN115518106A (zh) | 一种兽用胃肠道保健中药组合物制剂及其制备方法 | |
CN103251103B (zh) | 防辐射果蔬饮料及其制备方法 | |
CN110314186B (zh) | 一种防治水产动物肠炎的中药组合物及其制备方法 | |
CN112293740A (zh) | 一种增强免疫力的组合物及其制备方法和应用 | |
TWI238852B (en) | A new extraction method and application of antrodia camphorata to reduce the damage from chemotherapy for cancer and enhance the erythropoiesis in bone marrow | |
CN1327047A (zh) | 一种用蚕蛹培养拟青霉菌的方法及药用用途 | |
CN118059188B (zh) | 一种长双歧杆菌sf-b-60后生元菌剂及其制备方法和应用 | |
CN111643466B (zh) | 一种盐酸小檗碱片剂的制备方法 | |
KR100671847B1 (ko) | 착유우의 체세포 감소제 | |
CN117045691A (zh) | 血通菜提取物在抗幽门螺杆菌中的应用 | |
CN102119945A (zh) | 一种治疗气虚症的超声波提取中药制剂的制备方法 | |
JPH07196525A (ja) | 胃炎、胃・十二指腸潰瘍の予防及び治療剤 | |
CN107412607B (zh) | 一种芦笋胶囊及其制备方法 | |
CN115844929A (zh) | 一种可显著提高有效成分含量的螺旋藻胶囊及其制备方法 | |
CN116875572A (zh) | 一种提取超氧化物歧化酶的方法 | |
CN114533681A (zh) | 猫棒束孢菌丝粉的新用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211221 Address after: 130012 No. 2699 Qianjin Street, Changchun, Jilin, Chaoyang District Applicant after: Jilin University Applicant after: Jiangsu Qingbei Health Technology Co.,Ltd. Address before: 130012 No. 2699 Qianjin Street, Changchun, Jilin, Chaoyang District Applicant before: Jilin University |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20231222 Address after: 130012 No. 2699 Qianjin Street, Changchun, Jilin, Chaoyang District Applicant after: Jilin University Applicant after: High tech Zhongke (Jiangyin) Incubator Management Co.,Ltd. Address before: 130012 No. 2699 Qianjin Street, Changchun, Jilin, Chaoyang District Applicant before: Jilin University Applicant before: Jiangsu Qingbei Health Technology Co.,Ltd. |
|
TA01 | Transfer of patent application right |